Propofol spray - Manhattan Pharmaceuticals/NovaDel Pharma

Drug Profile

Propofol spray - Manhattan Pharmaceuticals/NovaDel Pharma

Alternative Names: Propofol lingual spray; Propofol LS

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Manhattan Pharmaceuticals; NovaDel Pharma
  • Developer Manhattan Pharmaceuticals
  • Class General anaesthetics; Phenols; Small molecules
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Sedation

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 27 Aug 2009 Propofol spray is still available for licensing (http://www.manhattanpharma.com)
  • 11 Feb 2008 Propofol spray is available for licensing (http://manhattanpharma.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top